HMHideto Miwa

Hideto Miwa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hideto Miwa has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chronic inflammatory demyelinating polyneuropathy associated with primary biliary cirrhosis

    by Ken-Ya Murata, Hiroshi Ishiguchi, Ryuki Ando, Hideto Miwa, Tomoyoshi Kondo


  • Avoidance of swallowing saliva: A symptom related to aberrant basal ganglia functions?

    by Hideto Miwa, Kaoru Tsuruta, Tomoyoshi Kondo

    We report two patients with avoidance of swallowing saliva despite intact swallowing functions. One, with mild, de novo Parkinson's disease, had a fear that his saliva was contaminated and would harm him. The other, with a history of CNS germinoma in remission for 3 years following chemotherapy, expectorated because his saliva was distasteful and disgusting. He had a lesion involving the left pallidum. Both appeared obsessed with the idea of saliva contamination and both expectorated compulsively, presenting obsessive-compulsive disorder (OCD) symptoms. OCD-like behavior may be induced in association with pathological conditions in which aberrant basal ganglia functions are present.


  • Ultrasonography of the diaphragm in amyotrophic lateral sclerosis: Clinical significance in assessment of respiratory functions

    by Yasuhiro Hiwatani, Mayumi Sakata, Hideto Miwa

    Our objective was to evaluate diaphragm thicknesses during respiration by ultrasonography, and compare with conventional measurements of respiratory functions in patients with amyotrophic lateral sclerosis (ALS). Thirty-six consecutive ALS patients and 19 age-matched healthy volunteers participated. Ultrasonography of the diaphragm in the zone of apposition was performed. Maximal diaphragm thickness during the maximal inspiratory effort (DTmax) and minimum diaphragm thickness at the end expiratory position (DTmin) were measured using ultrasonography. The thickening ratio (TR), defined as the ratio of DTmin to DTmax, was calculated. All patients underwent conventional pulmonary function testing. Arterial blood gas analysis was also performed. The diaphragm was clearly identifiable by ultrasonography. DTmax, DTmin and the TR were all significantly decreased in ALS patients with %VC (vital capacity) < 80, compared with those in either ALS patients with %VC ≥ 80 or healthy controls. DTmax, DTmin and the TR were all significantly correlated with %VC. In addition, significant inverse correlations were found between all three parameters and pCO2. The inter-observer reliability of measurements of diaphragm thickness was high. In conclusion, sonography of the diaphragm can provide additional or complementary information for assessing respiratory functions in patients with ALS.


    • 1 August 2012
      • Vol. 64  (8) , 951-5

    [Neuromyelitis optica following thymectomy with severe spinal cord atrophy after frequent relapses for 30 years].

    by Masaya Hironishi, Shinji Ishimoto, Tadashi Sawanishi, Hideto Miwa, Izumi Kawachi, Tomoyoshi Kondo

    A 60-year-old woman had frequent relapses of neuromyelitis optica (NMO) for 30 years despite receiving steroid and azathioprine therapy. She developed MGFA Class IIIb type of myasthenia gravis (MG) at the age of 23, and thymectomy resulted in complete remission of MG. The initial symptoms of NMO, including headache, high fever, retrobulbar optic neuritis, and neurogenic bladder, appeared at the age of 30. Two years later, paraplegia also developed. Although she received oral administration of steroids or azathioprine and intravenous steroid pulse therapy for treatment of NMO for over 30 years, she experienced frequent relapses. The examination at the ages of 58 and 60 years showed that anti-aquaporin-4 antibody was absent. Intravenous immunoglobulin therapy administered in January and June 2009 was effective, and she had 2 years of remission of NMO attack. Spinal MRI after frequent NMO attacks for 30 years revealed an extended spinal cord atrophy involving the lower cervical region and the entire thoracic region. We describe and discuss the prognosis of NMO and the effectiveness of therapies in an NMO patient who underwent thymectomy for MG.


    • 1 April 2012
      • Vol. 64  (4) , 413-22

    [Transcranial sonography findings in Parkinson's disease].

    by Masae Izawa Okawa, Hideto Miwa

    Interest in diagnostic biomarkers that improve identification of Parkinson's disease (PD) in the early stages has been recently increasing. Accurate diagnosis of PD is currently a challenge for clinical neurologists. In addition, recent advances in basic research towards neuroprotective strategies for PD are increasingly highlighting the need for diagnostic biomarkers that improve identification of PD in the early stages. As such, substantia nigra hyperechogenicity visualized by transcranial sonography (TCS) has gained increasing attention and has been implemented in PD diagnosis globally. As substantia nigra hyperechogenicity offers unique information supplementary to those provided by other neuroimaging techniques, and this echofeature is stable during the disease course, it is very helpful in early and differential diagnosis of PD. The pathophysiologic conditions underlying this echofeature are not fully understood; however, it maybe associated with increased amounts of iron. It should be reminded that there are several limitations in conducting TCS. The main limitation is that in Japanese subjects the rate of temporal bone window sufficient for an adequate sonographic analysis prominently decreases with advancing age, particularly in females. Another limitation is that measurements may vary between two laboratories. Therefore, investigators are required to generate their own reference values. Despite these limitations, TCS can be recommended as a useful technique for the diagnosis of PD owing to its fast and easy use, low cost, and noninvasive nature. This review summarizes the TCS technique, the typical findings, and their value in the diagnosis and differential diagnosis of PD.


  • T-Type Calcium Channel as a New Therapeutic Target for Tremor

    by Hideto Miwa, Tomoyoshi Kondo

    Voltage-gated calcium channels play an important role in many physiological and pathological processes. Accumulating studies suggest that the T-type calcium channel is a potential target for the treatment of various neurological disorders, such as epilepsy, insomnia, and neuropathic pain. Here, we highlight recent advances in our understanding of T-type calcium channel regulation and their implications for tremor disorders. Several T-type calcium channel blockers effectively suppressed experimental tremors that have been suggested to originate from either the cerebellum or basal ganglia. Among T-type calcium channel blockers that have been used clinically, the anti-tremor efficacy of zonisamide garnered our attention. Based on both basic and clinical studies, the possibility is emerging that T-type calcium channel blockers that transit into the central nervous system may have therapeutic potentials for tremor disorders.


  • Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats

    by Hideto Miwa, Jinsoo Koh, Yoshinori Kajimoto, Tomoyoshi Kondo


  • Bicycle Sign for Differential Diagnosis of Parkinsonism: Is it of Use in a Hilly Country Like Japan?

    by Hideto Miwa, Tomoyoshi Kondo

    The loss of the ability to cycle after disease onset, the so-called “bicycle sign”, has been proposed as a new red flag for atypical parkinsonism. However, actual environments or situations for bicycling differ from one country to another, raising the question of whether “bicycle sign” could be universally applicable. The present study suggested that “bicycle sign” could contribute to earlier and better differential diagnosis of parkinsonism in a hilly country like Japan.


  • Open Access

    Fatigue in Patients with Parkinson's Disease: Impact on Quality of Life

    by Hideto Miwa, Takako Miwa

    Objective To determine the prevalence of fatigue and factors associated with fatigue in patients with Parkinson's disease (PD). Methods Fatigue was evaluated using the PD Fatigue Scale, a self-report questionnaire consisting of 16 statements describing the severity of fatigue symptoms. Patients were also evaluated using the Unified PD Rating Scale, Zung Depression Scale, the Epworth Sleepiness Scale, the PD Questionnaire-39 (PDQ-39) for assessing quality of life (QOL), and the Apathy Scale. Patients We examined 46 consecutive outpatients clinically diagnosed with PD, excluding patients with cognitive impairment. Results Fatigue was present in 22 (48%) patients. Multiple logistic regression analysis indicated that only QOL-scores and Apathy Scale scores were significant independent variables related to the presence of fatigue. Conclusion Fatigue is a common symptom in patients with PD, and it is a symptom closely related to impaired QOL.